Business Description
OncoTherapy Science Inc
ISIN : JP3202150003
Description
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.65 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -17.7 | |||||
| Beneish M-Score | -4.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15 | |||||
| 3-Year EBITDA Growth Rate | 12.5 | |||||
| 3-Year EPS without NRI Growth Rate | 15.6 | |||||
| 3-Year FCF Growth Rate | 17.4 | |||||
| 3-Year Book Growth Rate | -54.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.13 | |||||
| 9-Day RSI | 38.61 | |||||
| 14-Day RSI | 36.94 | |||||
| 6-1 Month Momentum % | -3.13 | |||||
| 12-1 Month Momentum % | 63.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.55 | |||||
| Quick Ratio | 3.11 | |||||
| Cash Ratio | 2.61 | |||||
| Days Inventory | 57.7 | |||||
| Days Sales Outstanding | 27.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.3 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -29.13 | |||||
| Operating Margin % | -183.7 | |||||
| Net Margin % | -211.13 | |||||
| FCF Margin % | -201.7 | |||||
| ROE % | -174.95 | |||||
| ROA % | -114.14 | |||||
| ROIC % | -636.85 | |||||
| ROC (Joel Greenblatt) % | -3200.14 | |||||
| ROCE % | -154.9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 8.39 | |||||
| PB Ratio | 6.52 | |||||
| Price-to-Tangible-Book | 6.79 | |||||
| EV-to-EBIT | -4.43 | |||||
| EV-to-EBITDA | -4.43 | |||||
| EV-to-Revenue | 9.34 | |||||
| EV-to-FCF | -4.41 | |||||
| Price-to-Median-PS-Value | 0.33 | |||||
| Price-to-Net-Current-Asset-Value | 7.14 | |||||
| Price-to-Net-Cash | 12.32 | |||||
| Earnings Yield (Greenblatt) % | -22.57 | |||||
| FCF Yield % | -18.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OncoTherapy Science Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 610.118 | ||
| EPS (TTM) (円) | -6.073 | ||
| Beta | 0.69 | ||
| Volatility % | 87.09 | ||
| 14-Day RSI | 36.94 | ||
| 14-Day ATR (円) | 2.054763 | ||
| 20-Day SMA (円) | 27.95 | ||
| 12-1 Month Momentum % | 63.16 | ||
| 52-Week Range (円) | 15 - 64 | ||
| Shares Outstanding (Mil) | 271.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OncoTherapy Science Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OncoTherapy Science Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
OncoTherapy Science Inc Frequently Asked Questions
What is OncoTherapy Science Inc(TSE:4564)'s stock price today?
The current price of TSE:4564 is 円25.00. The 52 week high of TSE:4564 is 円64.00 and 52 week low is 円15.00.
When is next earnings date of OncoTherapy Science Inc(TSE:4564)?
The next earnings date of OncoTherapy Science Inc(TSE:4564) is .
Does OncoTherapy Science Inc(TSE:4564) pay dividends? If so, how much?
OncoTherapy Science Inc(TSE:4564) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers